{"id":909254,"date":"2025-11-12T17:33:47","date_gmt":"2025-11-12T22:33:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/"},"modified":"2025-11-12T17:33:47","modified_gmt":"2025-11-12T22:33:47","slug":"tyra-biosciences-announces-participation-at-upcoming-investor-events-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/","title":{"rendered":"Tyra Biosciences Announces Participation at Upcoming Investor Events"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">CARLSBAD, Calif.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Nov. 12, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events:<\/p>\n<p class=\"prnml40\">\n        <b>Jefferies London Healthcare Conference<br \/><\/b>Format: Hybrid presentation (slides &amp; moderated Q&amp;A) and one-on-one investor meetings<br \/>Presentation Date\/Time: <span class=\"xn-chron\">Wednesday, November 19, 2025<\/span>, at <span class=\"xn-chron\">4:00 PM GMT<\/span><br \/>Location: <span class=\"xn-location\">London, UK<\/span><\/p>\n<p class=\"prnml40\">\n        <b>37<sup>th<\/sup> Annual Piper Healthcare Conference<\/b><br \/>\n        <br \/>Format: One-on-one investor meetings<br \/>Date: <span class=\"xn-chron\">December 2-4, 2025<\/span><br \/>Location: <span class=\"xn-location\">New York, NY<\/span><\/p>\n<p>A live webcast of the\u00a0Jefferies event can be accessed by visiting the &#8220;For Investors&#8221; page on the\u00a0Tyra Biosciences\u00a0<b><u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4556136-1&amp;h=556906206&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4492013-1%26h%3D1419926496%26u%3Dhttps%253A%252F%252Fir.tyra.bio%252F%26a%3Dwebsite&amp;a=website\" target=\"_blank\" rel=\"nofollow\">website<\/a><\/u><\/b>\u00a0and will be available for replay following the event.<\/p>\n<p>\n        <b>About Tyra Biosciences<\/b>\n      <\/p>\n<p>Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. TYRA&#8217;s in-house precision medicine platform, SN\u00c5P, enables rapid and precise drug design through iterative molecular SN\u00c5Pshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA&#8217;s expertise in FGFR biology has created a differentiated pipeline with clinical-stage programs in targeted oncology and genetically defined conditions. TYRA&#8217;s lead precision medicine stemming from SN\u00c5P, dabogratinib, is a potential first-in-class selective FGFR3 inhibitor. Dabogratinib&#8217;s current planned clinical development includes BEACH301 for pediatric achondroplasia (ACH), SURF302 for intermediate-risk non-muscle invasive bladder cancer (IR-NMIBC), SURF303 for low-grade upper tract urothelial carcinoma (LG-UTUC) and potentially metastatic urothelial carcinoma (mUC). TYRA is also developing TYRA-430, an oral, investigational FGFR4\/3-biased inhibitor for FGF19+\/FGFR4-driven cancers, in the SURF431 study for advanced hepatocellular carcinoma, and TYRA-200, an oral, investigational, FGFR1\/2\/3 inhibitor, in the SURF201 study for metastatic intrahepatic cholangiocarcinoma. TYRA is based in <span class=\"xn-location\">Carlsbad, CA.<\/span><\/p>\n<p>For more information about our science, pipeline and people, please visit\u00a0 <u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4556136-1&amp;h=3416189170&amp;u=http%3A%2F%2Fwww.tyra.bio%2F&amp;a=www.tyra.bio\" target=\"_blank\" rel=\"nofollow\">www.tyra.bio<\/a><\/u>\u00a0and engage with us on <u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4556136-1&amp;h=2278272121&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftyra-biosciences%2F%3FviewAsMember%3Dtrue&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a><\/u>.<\/p>\n<p>\n        <b>Contact:<\/b>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Amy Conrad<\/span><br \/>\n        <br \/>\n        <u><br \/>\n          <a href=\"mailto:aconrad@tyra.bio\" target=\"_blank\" rel=\"nofollow\">aconrad@tyra.bio<\/a><br \/>\n        <\/u>\n      <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1500\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg\" title=\"(PRNewsfoto\/Tyra Biosciences, Inc.)\" alt=\"(PRNewsfoto\/Tyra Biosciences, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA22222&amp;sd=2025-11-12\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/tyra-biosciences-announces-participation-at-upcoming-investor-events-302613236.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/tyra-biosciences-announces-participation-at-upcoming-investor-events-302613236.html<\/a><\/p>\n<p>SOURCE  Tyra Biosciences<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA22222&amp;Transmission_Id=202511121605PR_NEWS_USPR_____LA22222&amp;DateId=20251112\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire CARLSBAD, Calif. , Nov. 12, 2025 \/PRNewswire\/ &#8212; Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: Jefferies London Healthcare ConferenceFormat: Hybrid presentation (slides &amp; moderated Q&amp;A) and one-on-one investor meetingsPresentation Date\/Time: Wednesday, November 19, 2025, at 4:00 PM GMTLocation: London, UK 37th Annual Piper Healthcare Conference Format: One-on-one investor meetingsDate: December 2-4, 2025Location: New York, NY A live webcast of the\u00a0Jefferies event can be accessed by visiting the &#8220;For Investors&#8221; page on the\u00a0Tyra Biosciences\u00a0website\u00a0and will be available for replay following the event. About Tyra Biosciences Tyra &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tyra Biosciences Announces Participation at Upcoming Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-909254","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire CARLSBAD, Calif. , Nov. 12, 2025 \/PRNewswire\/ &#8212; Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: Jefferies London Healthcare ConferenceFormat: Hybrid presentation (slides &amp; moderated Q&amp;A) and one-on-one investor meetingsPresentation Date\/Time: Wednesday, November 19, 2025, at 4:00 PM GMTLocation: London, UK 37th Annual Piper Healthcare Conference Format: One-on-one investor meetingsDate: December 2-4, 2025Location: New York, NY A live webcast of the\u00a0Jefferies event can be accessed by visiting the &#8220;For Investors&#8221; page on the\u00a0Tyra Biosciences\u00a0website\u00a0and will be available for replay following the event. About Tyra Biosciences Tyra &hellip; Continue reading &quot;Tyra Biosciences Announces Participation at Upcoming Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-12T22:33:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tyra Biosciences Announces Participation at Upcoming Investor Events\",\"datePublished\":\"2025-11-12T22:33:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/\"},\"wordCount\":341,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1626125\\\/Tyra_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/\",\"name\":\"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1626125\\\/Tyra_Logo.jpg\",\"datePublished\":\"2025-11-12T22:33:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1626125\\\/Tyra_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1626125\\\/Tyra_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tyra Biosciences Announces Participation at Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/","og_locale":"en_US","og_type":"article","og_title":"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk","og_description":"PR Newswire CARLSBAD, Calif. , Nov. 12, 2025 \/PRNewswire\/ &#8212; Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: Jefferies London Healthcare ConferenceFormat: Hybrid presentation (slides &amp; moderated Q&amp;A) and one-on-one investor meetingsPresentation Date\/Time: Wednesday, November 19, 2025, at 4:00 PM GMTLocation: London, UK 37th Annual Piper Healthcare Conference Format: One-on-one investor meetingsDate: December 2-4, 2025Location: New York, NY A live webcast of the\u00a0Jefferies event can be accessed by visiting the &#8220;For Investors&#8221; page on the\u00a0Tyra Biosciences\u00a0website\u00a0and will be available for replay following the event. About Tyra Biosciences Tyra &hellip; Continue reading \"Tyra Biosciences Announces Participation at Upcoming Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-12T22:33:47+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tyra Biosciences Announces Participation at Upcoming Investor Events","datePublished":"2025-11-12T22:33:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/"},"wordCount":341,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/","name":"Tyra Biosciences Announces Participation at Upcoming Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg","datePublished":"2025-11-12T22:33:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1626125\/Tyra_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tyra-biosciences-announces-participation-at-upcoming-investor-events-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tyra Biosciences Announces Participation at Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/909254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=909254"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/909254\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=909254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=909254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=909254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}